Bacterial extracts cultured in thermal waters comprising anti-redness agents
US-9770474-B2 · Sep 26, 2017 · US
US11371010B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11371010-B2 |
| Application number | US-201615353173-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 16, 2016 |
| Priority date | May 10, 2007 |
| Publication date | Jun 28, 2022 |
| Grant date | Jun 28, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a process for the preparation of a cosmetic or dermatological active principle, comprising the culturing of at least one nonphotosynthetic and nonfruiting filamentous bacterium on a medium comprising at least one nonsulphurous mineral and/or thermal water.It also relates to a cosmetic or dermatological composition comprising at least one bacterium of the genus Vitreoscilla or one of its extracts.
Opening claim text (preview).
The invention claimed is: 1. A process for preparing a cosmetic or dermatological active principle, comprising: culturing at least one nonphotosynthetic and nonfruiting filamentous bacterium comprising an envelope on a medium comprising at least one first water which is thermal water from La Roche-Posay, the first water being mixed with at least one second water which is an osmotically treated and/or distilled water and the concentration of the first water is from 0.5% to 50% with respect to the second water to produce a cultured bacterium comprising an envelope, wherein the at least one first water exhibits a total mineral content of greater than or equal to 400 mg/l; separating the cultured bacterium from the medium, and rupturing the envelope of the cultured bacterium to produce the active principle. 2. The process according to claim 1 , wherein a genus of the bacterium is the genus Vitreoscilla. 3. The process according to claim 2 , wherein a specie of the bacterium is the specie, Vitreoscilla filiformis. 4. The process according to claim 3 , wherein the bacterium is the strain deposited at the ATCC under the reference ATCC15551. 5. The process according to claim 1 , wherein a concentration of calcium ions in the first water is greater than or equal to 100 mg/l. 6. The process according to claim 1 , wherein a concentration of hydrogen-carbonates in the first water is greater than or equal to 300 mg/l. 7. The process according to claim 1 , comprising: fermenting the cultured bacterium in the medium prior to separating the cultured bacterium from the medium to produce a fermented cultured bacterium; and separating the fermented cultured bacterium from the medium to recover a mass of the bacteria; wherein the medium further comprises a monosaccharide, and the bacterium is of the order Beggiatoales. 8. The process according to claim 7 , further comprising: stabilizing the mass of the bacteria which is recovered after fermentation. 9. The process according to claim 1 , wherein the medium comprises a mixture of (i) osmotically treated or distilled water and of (ii) thermal water, and a ratio (i)/(ii) is between 1 and 100. 10. The process according to claim 1 , wherein the at least one first water exhibits a total mineral content of 400 mg/1 to 900 mg/l. 11. The process according to claim 1 , wherein the medium comprises a mixture of (i) osmotically treated or distilled water and of (ii) thermal water, and a ratio (i)/(ii) is between 1 and 25. 12. A process for preparing a cosmetic or dermatological active principle, comprising: culturing at least one nonphotosynthetic and nonfruiting filamentous bacterium on a medium comprising at least one first water which is thermal water from La Roche-Posay, the first water being mixed with at least one second water which is an osmotically treated and/or distilled water and the concentration of the first water is from 0.5% to 50% with respect to the second water to produce a cultured bacterium, wherein the at least one first water exhibits a total mineral content of greater than or equal to 400 mg/l; and separating the cultured bacterium from the medium to prepare an extract of the medium, wherein the extract is the active principle. 13. The process according to claim 12 , wherein the extract is supernatant from the medium. 14. The process according to claim 1 , wherein the concentration of the first water is from 0.5% to 20% with respect to the second water. 15. The process according to claim 1 , wherein the concentration of the first water is from 0.5% to 2% with respect to the second water. 16. The process according to claim 12 , wherein the concentration of the first water is from 0.5% to 20% with respect to the second water. 17. The process according to claim 12 , wherein the concentration of the first water is from 0.5% to 2% with respect to the second water.
Related publications grouped by family.
Answers are generated from the same data shown on this page.